Navigation Links
Angiotech announces preliminary third quarter financial results and updates fiscal 2007 outlook
Date:10/19/2007

y complete preclinical and clinical development of our products; changes in business strategy or development plans; our failure to obtain patent protection for discoveries; loss of patent protection resulting from third party challenges to our patents; commercialization limitations imposed by patents owned or controlled by third parties; our ability to obtain rights to technology from licensors; liability for patent claims and other claims asserted against us; our ability to obtain and enforce timely patent and other intellectual property protection for our technology and products; the ability to enter into, and to maintain, corporate alliances relating to the development and commercialization of our technology and products; market acceptance of our technology and products; our ability to successfully manufacture, market and sell our products; the ability of Boston Scientific Corporation to successfully manufacture, market and sell their paclitaxel-eluting coronary stent products; the continued availability of capital to finance our activities; our ability to continue to integrate into our business the operations of American Medical Instruments Holdings, Inc. ("AMI"); our ability to achieve the operational and other synergies and the other commercial or financial benefits expected as a result of the acquisition of AMI; and any other factors referenced in our annual information form and other filings with the applicable Canadian securities regulatory authorities or the SEC. Given these uncertainties, assumptions and risk factors, readers are cautioned not to place undue reliance on such forward-looking statements. We disclaim any obligation to update any such factors or to publicly announce the result of any revisions to any of the forward-looking statements contained in this press release to reflect future results, events or developments.

TAXUS(R) is a registered trademark of Boston Scientific Corporation.

Quill(TM) is a trademark of Quill Medical, Inc.,
'/>"/>

SOURCE Angiotech Pharmaceuticals, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11

Related biology technology :

1. Speaker announces business members of IT Task Force
2. Doyle announces technology tax credits for Berbee
3. Doyle announces new energy, global warming policies
4. Doyle announces $80M renewable energy strategy
5. GE announces first installation of Discovery VCT
6. UWM announces winners of RGI awards
7. Third Wave announces two senior management appointments
8. Mirus announces new method for making antibodies
9. Merge announces sofware updates, upcoming acquisition
10. Small Tree announces ethernet solution for Apple Xserv G5
11. TEKLYNX International announces new RFID software
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/3/2015)... LITTLE FALLS, N.J. , March 3, 2015 /PRNewswire/ ... a biotechnology company specializing in the development of and ... of damaged tissues and organs, announced today that it ... Purchase Agreement with Amarantus Bioscience Holdings, Inc. (OTC Bulletin ... required under the Agreement, Amarantus made the final payments ...
(Date:3/3/2015)... PARSIPPANY, N.J. , March 3, 2015  Thingee ... industry, will be delivering a presentation entitled, "Technology Adoption: ... Conference, Thriving through Innovations and Technology ,  in ... from March 11 to 13, 2015. Audiences looking to ... more effectively will want to be in the audience ...
(Date:3/3/2015)... Genedata, a leading provider of ... science research, today announced that Pfizer Inc. has ... use at Pfizer biopharma research and development sites ... Pfizer’s global deployment and roll out project at ... Innovation (CTI), and Pharmaceutical Sciences groups. , ...
(Date:3/3/2015)... , March 3, 2015  Johnson & Johnson Innovation ... South San Francisco (JLABS @SSF), a 30,000-square ... South San Francisco, Calif. The Johnson ... to 50 startups from across the healthcare spectrum including ... The first resident startups have been selected, ...
Breaking Biology Technology:Regenicin (RGIN) Receives $2.3 Million in Final Payment from Amarantus 2Regenicin (RGIN) Receives $2.3 Million in Final Payment from Amarantus 3Thingee to present at 11th Annual Synergistix Users Conference 2Genedata Biologics Licensed by Pfizer Inc. 2Genedata Biologics Licensed by Pfizer Inc. 3Johnson & Johnson Innovation Opens JLABS @South San Francisco and Announces First Five Resident Startups 2Johnson & Johnson Innovation Opens JLABS @South San Francisco and Announces First Five Resident Startups 3Johnson & Johnson Innovation Opens JLABS @South San Francisco and Announces First Five Resident Startups 4Johnson & Johnson Innovation Opens JLABS @South San Francisco and Announces First Five Resident Startups 5
... Tianyin,Pharmaceutical, Inc., (OTC Bulletin Board: VSCO), a manufacturer ... in Chengdu,China, today announced that Mr. Stewart Lor, ... a conference call to update shareholders on the ... will take place at 4:15 p.m. EST, on ...
... YORK, Feb. 7 In a speech to ... UBS Global Health Services Conference,at the New York ... former Wisconsin Governor Tommy Thompson, will propose that,prevention ... The 18th annual,conference brings together experts from throughout ...
... patients with gene variant drink less, ... makeup often,plays a role in determining the ... new evidence-based research also shows a correlation,between ... Investigators participating in the National Institute ...
Cached Biology Technology:Tianyin Pharmaceutical, Inc. to Host 2008 Second Quarter Earnings Conference Call on Thursday, February 14, 2008 at 4:15 p.m. EST 2U.S. Preventive Medicine National Policy Advisor Gov. Tommy Thompson to Propose Prevention is the Solution at UBS Global Health Services Conference 2DNA Predicts Reaction to Drug That Fights Alcohol Dependence 2
(Date:3/2/2015)... , March 2, 2015   Neurotechnology , a ... introduced the SentiGaze Software Development Kit (SDK). ... applications that use off-the-shelf webcams to track eye movements ... at a monitor. Heatmaps can be used for applications ... of online advertising. The SDK can also be used ...
(Date:2/23/2015)... 23, 2015 NXT-ID, Inc. (NASDAQ: ... biometric authentication company focused on the growing mobile commerce ... 62114357 for DISTRIBUTED VOICE DIRECTED PAYMENT METHOD ... a new groundbreaking payment method. Payment accounts may be ... only be accessed if both the speech (the word ...
(Date:2/12/2015)... Conn. , Feb. 12, 2015 NXT-ID, ... or the "Company"), a biometric authentication company focused on ... has filed provisional patent 62/113114 for DISTRIBUTED ... DEVICES. The patent further establishes NXT-ID,s position ... its intellectual property portfolio the ability for multiple devices ...
Breaking Biology News(10 mins):Neurotechnology Releases SentiGaze SDK for Eye Movement Tracking Using Ordinary Webcams 2Neurotechnology Releases SentiGaze SDK for Eye Movement Tracking Using Ordinary Webcams 3NXT-ID Patents Voice Directed Payments 2NXT-ID Patents Voice Directed Payments 3NXT-ID Patents Collaborative Services to Enable the "Internet of Things" 2NXT-ID Patents Collaborative Services to Enable the "Internet of Things" 3
... plants from freezing are placed in storage during the ... In the current issue of the Proceedings of ... Distinguished Professor of molecular genetics, demonstrates how the CBF ... warmer months when days are long, and how it,s ...
... fats have been linked to ailments like heart disease and diabetes, ... well documented health benefits. So why do our bodies ... A new hypothesis described in latest issue of The Quarterly ... different fats interact with the microbes in our guts. According to ...
... (Aug. 27, 2012) -- Refrigerating coal-plant emissions would reduce levels ... carbon dioxide by more than 90 percent -- at a ... formula designed by a team of University of Oregon physicists. ... electronic spreadsheet, appeared in Physical Review E , a ...
Cached Biology News:The Quarterly Review of Biology: Why some fats are worse than others 2Cooled coal emissions would clean air and lower health and climate-change costs 2Cooled coal emissions would clean air and lower health and climate-change costs 3
... Lambda Free Light Chain ... of human immunoglobulin. Specificity: ... epitope of lambda chain. Reacts with ... lambda chains but not with lambda ...
Cells are grown to a specified density and induced, when necessary. Protein expression samples are collected at 3 growth points and analyzed by SDS-PAGE/Coomassie....
... Affinity Life Sciences provides cost effective ... recombinant proteins or monoclonal antibodies. Quality at ... and whether you require research or commercial ... various production methods such as roller bottles, ...
... are optimized for maximum packaging efficiencies of ... efficiency extracts (> 109 pfu/g with control ... library containing at least 5 107 ... are made from a specially designed phage ...
Biology Products: